Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum

Annals of Surgical Oncology

Volumn 15, Issue 4, 2008, Pages 1107-1116

  Wanebo, Harold J ^a   DiSiena, Michael ^a   Begossi, Giovanni ^a   Belliveau, James ^a   Gustafson, Eric ^a  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Isolated pelvic perfusion; Recurrent rectal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; ANALGESIA; AREA UNDER THE CURVE; BALLOON OCCLUSION; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CONTINUOUS INFUSION; DISTANT METASTASIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; HUMAN; INOPERABLE CANCER; ISOLATED PELVIC PERFUSION; PALLIATIVE THERAPY; RADIATION DOSE; RECTUM CANCER; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR REGRESSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PALLIATIVE CARE; RECTAL NEOPLASMS;

EID: 40549137788     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9652-9     Document Type: Conference Paper

References (15)

1. Creech O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: Regional perfusion utilizing an extra corporeal circuit. Ann Surg 1958; 148:616-32
2. Watkins E Jr, Hering AC, Luna R, Adams HD. The use if intravascular balloon catheters for isolation of the pelvic bed during pup oxygenator perfusion of cancer chemotherapeutic agents. Surg Gynecol Obstet 1960; 111:464-8
3. Wile A, Smolin M. Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. Arch Surg 1987; 122:1321-5
4. Turk PS, Belliveau JF, Darnowski JW, et al. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg 1993; 128:533-6
5. Wanebo HJ, Chung MA, Levy AI, Turk PS, Vezeridis MP, Belliveau JF. Preoperative therapy for advanced pelvic malignancy by isolated pelvic perfusion with balloon-occlusion technique. Ann Surg Oncol 1996; 3:295-303
6. Wanebo HJ, Belliveau JF. A pharmacokinetic model, and the clinical pharmacology of cis-platinum, 5-flourouracil and mitomycin-C in isolated pelvic perfusion. Cancer Chemother Pharmacol 1999; 43:427-34
7. Hoekstra HJ, Naujocks T. Koops HS, et al. Continuous leaking monitoring during hyperthermic isolated regional perfusion of the lower limb: techniques and results. Reg Cancer Treat 1992; 4:301-4
8. Lejeune FJ, Lienard D, Leyvraz S, et al. Regional chemotherapy of melanoma. Eur J Cancer 1993; 294:606-12
9. Thom AK, Alexander Hr, Andrich MP, Barker WC, Rosenberg SA, Fraker DL. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan. J Clin Oncol 1995; 13:264-73
10. Muchmore JH, Krementz ET, Carter RD, Preslan JE, George WI. Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltration. Arch Surg 1991; 126:1390-6
11. Turk PS, Wanebo HJ, Belliveau J, et al. Hemofiltration vs. charcoal hemoperfusion for venous extraction of regional chemotherapy. Manuscript submitted
12. Miller DG, Lawrence W. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy. Arch Surg 1962; 85: 430-41
13. Nord LD, Stolfi RL, Martin DS. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue: correlation of antitumor activity with dosage and Fura incorporation into RNA. Biochem Pharmacol 1992; 43:2543-9
14. Delaney M, Stancu M, Begossi G, Elfenbein GJ, Wanebo HJ. Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer. Med Health Rhode Island 2003; 86(8):252-5
15. Dedrich RL. Arterial drug infusion: Pharmacokinetic implications: problems and pitfalls. Cancer 1986; JNCI80:84-9